LUCIUS 卢修斯 米托坦 Mitotane肾上腺皮质癌

米托坦

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Mitotane

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

肾上腺皮质癌

Each tablet contains Mitotane ............. 500 m

LUCIUS

LUCIMITO is indicated for the treatment of

PHARMACEUTICALS

patients with inoperable. functional or
nonfunctional, adrenal cortical carcinoma.

Dosage and User
The recommended initial dose of LUCIMITO
is 2 g to 6 g orally, in three or four divided

LUCIMITO

doses per eay. merease doses Ierementally to
aciiere a dlood toncentration of 14 to 20 mo/l
or as tolerated. LUCIMITO is a cutotoxic dru
Follow annlicable snecin
pecial nandling and

141020mgL,

MITOTANE TABLETS

FDA批准

Tablets should be swallowed whole & not
Storage: in a dry place and store at 20C to 25C.

500mg

Warning:
Keep medicine ont
icine out of reach of Children. Do not
aumimster LUCIMITO during Pregnancy and
Lactation.

PLEASE SEE PACKAGEINSERT

100 Tablets

Manufactured and Marketed by:
I LUCIUS

权威认证

Thongmang village. Xaythany district,

Vientiane CanitaL. Laos

Warning: To be sold by retail on prescrgluon
registered physicians only, and as directed
by the nhusear

Rx Only

口碑质量

适应症:
用于治疗无法手术、功能性或非功能性肾上腺皮质癌。
推荐剂量:
1、初始剂量:每天口服2克至6克,分三次或四次给药。
2、逐渐增加剂量,以达到14至20mg/L的血液浓度,或达到可
耐受的浓度。